These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33635913)

  • 61. Early two-dose measles vaccination schedule in Guinea-Bissau: good protection and coverage in infancy.
    Garly ML; Martins CL; Balé C; da Costa F; Dias F; Whittle H; Aaby P
    Int J Epidemiol; 1999 Apr; 28(2):347-52. PubMed ID: 10342702
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Factors affecting poor measles vaccination coverage in sub-Saharan Africa with a special focus on Nigeria: a narrative review.
    Majekodunmi OB; Oladele EA; Greenwood B
    Trans R Soc Trop Med Hyg; 2022 Aug; 116(8):686-693. PubMed ID: 35294971
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Progress Toward Measles Elimination - Pakistan, 2000-2018.
    Mere MO; Goodson JL; Chandio AK; Rana MS; Hasan Q; Teleb N; Alexander JP
    MMWR Morb Mortal Wkly Rep; 2019 Jun; 68(22):505-510. PubMed ID: 31170125
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Measles and rubella microarray array patches to increase vaccination coverage and achieve measles and rubella elimination in Africa.
    Richardson LC; Moss WJ
    Pan Afr Med J; 2020; 35(Suppl 1):3. PubMed ID: 32373254
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The unfinished measles immunization agenda.
    Strebel P; Cochi S; Grabowsky M; Bilous J; Hersh BS; Okwo-Bele JM; Hoekstra E; Wright P; Katz S
    J Infect Dis; 2003 May; 187 Suppl 1():S1-7. PubMed ID: 12721885
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Measles outbreak in complex emergency: estimating vaccine effectiveness and evaluation of the vaccination campaign in Borno State, Nigeria, 2019.
    Jean Baptiste AE; Wagai J; Luce R; Masresha B; Klinkenberg D; Veldhuijzen I; Oteri J; Dieng B; Ikeonu OC; Meleh S; Musa A; Braka F; Hahné S; Sanders EAM; Hak E
    BMC Public Health; 2021 Mar; 21(1):437. PubMed ID: 33663439
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Impact of state weights on national vaccination coverage estimates from household surveys in Nigeria.
    Dong TQ; Rhoda DA; Mercer LD
    Vaccine; 2020 Jul; 38(32):5060-5070. PubMed ID: 32532542
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Marked increase in measles vaccination coverage among young adults in Switzerland: a campaign or cohort effect?
    Altpeter E; Wymann MN; Richard JL; Mäusezahl-Feuz M
    Int J Public Health; 2018 Jun; 63(5):589-599. PubMed ID: 29675705
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Assessment of missed opportunities for vaccination (MOV) in Burkina Faso using the World Health Organization's revised MOV strategy: Findings and strategic considerations to improve routine childhood immunization coverage.
    Kaboré L; Meda B; Médah I; Shendale S; Nic Lochlainn L; Sanderson C; Ouattara M; Kaboré WMF; Betsem E; Ogbuanu IU
    Vaccine; 2020 Nov; 38(48):7603-7611. PubMed ID: 33077298
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Progress Toward Measles Elimination - European Region, 2009-2018.
    Zimmerman LA; Muscat M; Singh S; Ben Mamou M; Jankovic D; Datta S; Alexander JP; Goodson JL; O'Connor P
    MMWR Morb Mortal Wkly Rep; 2019 May; 68(17):396-401. PubMed ID: 31048675
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The challenges of insecurity on implementing vaccination campaign and its effect on measles elimination and control efforts: A case study of 2017/18 measles campaign in Borno state, Nigeria.
    Babakura B; Nomhwange T; Jean Baptiste AE; Dede O; Taiwo L; Abba S; Soyemi M; Idowu AM; Terna Richard M; Braka F; Oteri J; Shuaib F
    Vaccine; 2021 Nov; 39 Suppl 3():C66-C75. PubMed ID: 33546886
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Measles control in Kinshasa, Zaire improved with high coverage and use of medium titre Edmonston Zagreb vaccine at age 6 months.
    Cutts FT; Othepa O; Vernon AA; Nyandu B; Markowitz LE; Deforest A; Wilkins K; Okwo B
    Int J Epidemiol; 1994 Jun; 23(3):624-31. PubMed ID: 7960392
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Sustainable Development Goals and childhood measles vaccination in Ekiti State, Nigeria: Results from spatial and interrupted time series analyses.
    Ilesanmi MM; Adeyinka DA; Olakunde BO
    Vaccine; 2022 Jun; 40(28):3861-3868. PubMed ID: 35644673
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Evaluation of the mass measles vaccination campaign in Guangdong Province, China.
    Peng ZQ; Chen WS; He Q; Peng GW; Wu CG; Xu N; Zhao ZJ; Shu J; Tan Q; Zheng HZ; Lin LF; Deng HH; Lin JY; Zhang YH
    Int J Infect Dis; 2012 Feb; 16(2):e99-103. PubMed ID: 22119269
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Childhood full and under-vaccination in Nigeria, 2013.
    McGavin ZA; Wagner AL; Carlson BF; Power LE; Eboreime E; Boulton ML
    Vaccine; 2018 Nov; 36(48):7294-7299. PubMed ID: 30340882
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comparison of two survey methodologies to assess vaccination coverage.
    Luman ET; Worku A; Berhane Y; Martin R; Cairns L
    Int J Epidemiol; 2007 Jun; 36(3):633-41. PubMed ID: 17420165
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Avoiding missed opportunities for immunization in the Central African Republic: potential impact on vaccination coverage.
    Kahn JG; Mokdad AH; Deming MS; Roungou JB; Boby AM; Excler JL; Waldman RJ
    Bull World Health Organ; 1995; 73(1):47-55. PubMed ID: 7704925
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Field challenges to measles elimination in the Democratic Republic of the Congo.
    Coulborn RM; Nackers F; Bachy C; Porten K; Vochten H; Ndele E; Van Herp M; Bibala-Faray E; Cohuet S; Panunzi I
    Vaccine; 2020 Mar; 38(13):2800-2807. PubMed ID: 32111528
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Measles and rubella serosurvey identifies rubella immunity gap in young adults of childbearing age in Zambia: The added value of nesting a serological survey within a post-campaign coverage evaluation survey.
    Hayford K; Mutembo S; Carcelen A; Matakala HK; Munachoonga P; Winter A; Wanyiri JW; Searle K; Mwansa FD; Mwiche A; Phiri C; Book C; Thuma PE; Moss WJ
    Vaccine; 2019 Apr; 37(17):2387-2393. PubMed ID: 30905529
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Trends in measles cases in Bayelsa state, Nigeria: a five-year review of case-based surveillance data (2014-2018).
    Aworabhi-Oki N; Numbere T; Balogun MS; Usman A; Utulu R; Ebere N; Omubo W; Stow J; Abba S; Olorukooba A
    BMC Public Health; 2020 Jun; 20(1):938. PubMed ID: 32539691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.